ArticleJAMA oncology2019

Notice of Retraction and Replacement. Choi et al. Risk of hepatocellular carcinoma in patients treated with entecavir vs tenofovir for chronic hepatitis B: a Korean nationwide cohort study. JAMA Oncol. 2019;5(1):30-36.

Young-Suk Lim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.